NO20053860D0 - COP 1 for behandling av inflammatorisk tarmsykdom. - Google Patents

COP 1 for behandling av inflammatorisk tarmsykdom.

Info

Publication number
NO20053860D0
NO20053860D0 NO20053860A NO20053860A NO20053860D0 NO 20053860 D0 NO20053860 D0 NO 20053860D0 NO 20053860 A NO20053860 A NO 20053860A NO 20053860 A NO20053860 A NO 20053860A NO 20053860 D0 NO20053860 D0 NO 20053860D0
Authority
NO
Norway
Prior art keywords
cop
treatment
inflammatory bowel
bowel disease
disease
Prior art date
Application number
NO20053860A
Other languages
English (en)
Other versions
NO333579B1 (no
NO20053860L (no
Inventor
Rina Ahoroni
Ruth Amon
Basak Kayhan
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO20053860D0 publication Critical patent/NO20053860D0/no
Publication of NO20053860L publication Critical patent/NO20053860L/no
Publication of NO333579B1 publication Critical patent/NO333579B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20053860A 2003-01-21 2005-08-18 Anvendelse av kopolymer 1 for fremstilling av en farmasoytisk sammensetning for behandling av inflammatoriske tarmsykdommer. NO333579B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44113603P 2003-01-21 2003-01-21
PCT/IL2004/000054 WO2004064717A2 (en) 2003-01-21 2004-01-20 Cop 1 for treatment of inflammatory bowel diseases

Publications (3)

Publication Number Publication Date
NO20053860D0 true NO20053860D0 (no) 2005-08-18
NO20053860L NO20053860L (no) 2005-10-20
NO333579B1 NO333579B1 (no) 2013-07-15

Family

ID=32771907

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053860A NO333579B1 (no) 2003-01-21 2005-08-18 Anvendelse av kopolymer 1 for fremstilling av en farmasoytisk sammensetning for behandling av inflammatoriske tarmsykdommer.

Country Status (14)

Country Link
US (1) US8008258B2 (no)
EP (1) EP1592384B1 (no)
AU (1) AU2004206120B2 (no)
CA (1) CA2513567C (no)
DK (1) DK1592384T3 (no)
ES (1) ES2397836T3 (no)
MX (1) MXPA05007711A (no)
NO (1) NO333579B1 (no)
NZ (1) NZ569331A (no)
PT (1) PT1592384E (no)
RU (1) RU2339397C2 (no)
SI (1) SI1592384T1 (no)
WO (1) WO2004064717A2 (no)
ZA (1) ZA200505733B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2527760T3 (es) * 1998-07-23 2015-01-29 Yeda Research And Development Co., Ltd. Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos
ATE475883T1 (de) * 2001-12-04 2010-08-15 Teva Pharma Verfahren zur messung der wirkstärke von glatirameracetat
ES2560448T3 (es) * 2004-05-07 2016-02-19 Ares Trading S.A. Procedimientos de tratamiento de enfermedades con copolímeros aleatorios
US7655221B2 (en) 2004-05-07 2010-02-02 Peptimmune, Inc. Methods of treating disease with random copolymers
US8501198B2 (en) 2004-06-07 2013-08-06 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
WO2006029411A2 (en) * 2004-09-09 2006-03-16 Yeda Research And Development Co. Ltd. Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof
NZ556156A (en) * 2005-02-02 2010-03-26 Teva Pharma Process for producing acetate salts of polypeptides using hydrogenolysis
US20100167983A1 (en) * 2007-10-22 2010-07-01 Teva Pharmaceutical Industries, Ltd. Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
CA2732228A1 (en) * 2008-07-25 2010-01-28 The Johns Hopkins University Methods and compositions for treating and preventing autoimmune diseases
EA019998B9 (ru) 2009-08-20 2016-01-29 Йеда Рисерч Энд Дивелопмент Ко. Лтд. Терапия глатирамером ацетатом с низкой кратностью
USRE49251E1 (en) 2010-01-04 2022-10-18 Mapi Pharma Ltd. Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
US8759302B2 (en) * 2010-03-16 2014-06-24 Teva Pharmaceutical Industries, Ltd. Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
KR102157718B1 (ko) * 2010-07-26 2020-09-18 큐 바이올로직스 인코포레이티드 면역원성 소염 조성물
US8709433B2 (en) 2010-10-11 2014-04-29 Teva Pharmaceutical Industries Ltd. Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate
ES2601892T3 (es) 2011-04-21 2017-02-16 Mapi Pharma Limited Pentapolímero aleatorio para el tratamiento de enfermedades autoinmunes
WO2013009885A2 (en) 2011-07-11 2013-01-17 Momenta Pharmaceuticals, Inc. Evaluation of copolymer diethylamide
US8575198B1 (en) 2011-09-07 2013-11-05 Momenta Pharmaceuticals, Inc. In-process control for the manufacture of glatiramer acetate
CA2851510A1 (en) 2011-10-10 2013-04-18 Teva Pharmaceutical Industries Ltd. Single nucleotide polymorphisms useful to predict clinical response for glatiramer acetate
CA2884267A1 (en) 2012-10-10 2014-04-17 Teva Pharmaceutical Industries Ltd. Biomarkers predictive for clinical response for glatiramer acetate
UY35790A (es) 2013-10-21 2015-05-29 Teva Pharma Marcadores genéticos que predicen la respuesta al acetato de glatiramer
WO2015164979A1 (en) 2014-05-02 2015-11-05 Qu Biologics Inc. Anti-microbial immunomodulation
US9155775B1 (en) 2015-01-28 2015-10-13 Teva Pharmaceutical Industries, Ltd. Process for manufacturing glatiramer acetate product
US20210220428A1 (en) 2016-06-30 2021-07-22 Stem Cell Medicine Ltd. Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
US12097292B2 (en) 2016-08-28 2024-09-24 Mapi Pharma Ltd. Process for preparing microparticles containing glatiramer acetate
CN110382052A (zh) 2017-03-26 2019-10-25 Mapi医药公司 用于治疗进展型形式的多发性硬化症的格拉替雷储库系统
CN110709091A (zh) 2017-05-15 2020-01-17 干细胞医药有限公司 使用长效格拉替雷和脂肪源性干细胞治疗多发性硬化症
US11510946B2 (en) 2017-05-15 2022-11-29 Stem Cell Medicine Ltd. Treatment of multiple sclerosis with adipose-derived stem cells

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5800808A (en) * 1994-05-24 1998-09-01 Veda Research And Development Co., Ltd. Copolymer-1 improvements in compositions of copolymers
US5858964A (en) * 1995-04-14 1999-01-12 Yeda Research And Development Co. Ltd. Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of GVHD
US6214791B1 (en) * 1997-01-10 2001-04-10 Yeda Research And Development Co. Ltd. Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
AU766498B2 (en) * 1998-07-23 2003-10-16 President And Fellows Of Harvard College, The Synthetic peptides and methods of use for autoimmune disease therapies
ES2527760T3 (es) * 1998-07-23 2015-01-29 Yeda Research And Development Co., Ltd. Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos
IL141021A0 (en) * 1998-07-23 2002-02-10 Yeda Res & Dev Treatment of autoimmune conditions with copolymer 1 and related copolymers
ES2327301T3 (es) 1998-09-25 2009-10-27 Yeda Research And Development Co., Ltd. Polipeptidos relacionados con el copolimero 1 para su uso como marcadores de pesos moleculares y para uso terapeutico.
AU6281599A (en) * 1998-10-02 2000-04-26 Yeda Research And Development Co. Ltd. Alternate day administration of copolymer 1 for treating autoimmune diseases
EP1128839A4 (en) * 1998-11-12 2002-10-09 Yeda Res & Dev PHARMACEUTICAL COMPOSITIONS CONTAINING COPOLYMERS OF SYNTHETIC PEPTIDES AND METHODS FOR PREVENTING AND TREATING GVHD AND HVGD
US20010044416A1 (en) * 2000-01-20 2001-11-22 Mccluskie Michael J. Immunostimulatory nucleic acids for inducing a Th2 immune response
MXPA02008023A (es) 2000-02-18 2005-06-30 Yeda Res & Dev Formulaciones de copolimero 1 para dosificacion oral, nasal y pulmonar.
AU2003204344A1 (en) * 2002-05-23 2003-12-11 Milder, Dan George Compositions and methods for the treatment of autoimmune diseases and neurological disorders
WO2006029411A2 (en) * 2004-09-09 2006-03-16 Yeda Research And Development Co. Ltd. Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof

Also Published As

Publication number Publication date
RU2005126412A (ru) 2006-01-27
WO2004064717A3 (en) 2005-10-13
US8008258B2 (en) 2011-08-30
ZA200505733B (en) 2006-10-25
US20060264354A1 (en) 2006-11-23
NO333579B1 (no) 2013-07-15
PT1592384E (pt) 2013-01-28
DK1592384T3 (da) 2012-12-17
NO20053860L (no) 2005-10-20
NZ569331A (en) 2010-08-27
CA2513567C (en) 2012-10-23
AU2004206120B2 (en) 2009-09-24
SI1592384T1 (sl) 2013-03-29
ES2397836T3 (es) 2013-03-11
EP1592384A4 (en) 2008-12-31
MXPA05007711A (es) 2005-09-30
EP1592384B1 (en) 2012-10-31
RU2339397C2 (ru) 2008-11-27
CA2513567A1 (en) 2004-08-05
AU2004206120A1 (en) 2004-08-05
EP1592384A2 (en) 2005-11-09
WO2004064717A2 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
NO20053860D0 (no) COP 1 for behandling av inflammatorisk tarmsykdom.
NO20053211D0 (no) Forbindelser for behandling av metabolske forstyrrelser.
NL1026892A1 (nl) ó1,8!Naftyridin-2-onen en verwante verbindingen voor de behandeling van schizofrenie.
NO20031442L (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
NO20031443D0 (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20040097L (no) Kombinasjoner for behandling av inflammatoriske forstyrrelser
CY2013021I1 (el) Συνθεσεις για τη θεραπευτικη αγωγη γαστροεντερικων διαταραχων
NO20034590D0 (no) Fremgangsmåter for behandling av vaskul¶r sykdom
NO20041882L (no) Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
DE602004026245D1 (de) Endoskop
NO20041368D0 (no) Azabicyklus-substituerte kondenserte heteroarylforbindelser for behandling av sykdom
DE602004015286D1 (de) Wäschebehandlungsmittel
IL152127A0 (en) Probiotic compositions for the treatment of inflammatory bowel disease
ITVI20030037A1 (it) Tessuto ad elevate proprieta' ignifughe.
DE60316652D1 (de) Endoskop
NO20035522D0 (no) Kinuklidin-substituerte multisykliske heteroaryler for behandling av sykdom
NO20054598D0 (no) Beta-karboliner anvendbare for behandling av betennelsessykdommer
EP1592384A3 (en) Cop 1 for treatment of inflammatory bowel diseases
NL1026203A1 (nl) Verbindingen toepasbaar voor de behandeling van ziekten.
IS7163A (is) Aðferðir til meðhöndlunar á lungnasjúkdómi
NO20054034D0 (no) Fremgangsmate for behandling av hypotyroidisme.
IS8477A (is) Beta-laktöm til að meðhöndla MTK sjúkdóma
DE60328937D1 (de) Objektivdiagnostik
ATE433983T1 (de) Thiadibenzoazulenderivate zur behandlung von entzündlichen erkrankungen
ITMI20022263A1 (it) Composizioni per il trattamento delle emorroidi.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees